Qsemble Capital Management LP bought a new stake in The Cigna Group (NYSE:CI – Free Report) in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm bought 12,485 shares of the health services provider’s stock, valued at approximately $4,325,000.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. AQR Capital Management LLC grew its holdings in shares of The Cigna Group by 63.4% in the second quarter. AQR Capital Management LLC now owns 1,547,245 shares of the health services provider’s stock valued at $510,467,000 after acquiring an additional 600,215 shares in the last quarter. Swedbank AB bought a new stake in shares of The Cigna Group in the 1st quarter worth approximately $161,300,000. Ameriprise Financial Inc. grew its stake in shares of The Cigna Group by 23.4% during the 2nd quarter. Ameriprise Financial Inc. now owns 2,138,193 shares of the health services provider’s stock worth $706,822,000 after acquiring an additional 405,694 shares during the period. The Manufacturers Life Insurance Company boosted its position in The Cigna Group by 145.3% during the second quarter. The Manufacturers Life Insurance Company now owns 683,361 shares of the health services provider’s stock worth $225,899,000 after purchasing an additional 404,791 shares during the period. Finally, International Assets Investment Management LLC boosted its position in The Cigna Group by 49,287.7% during the third quarter. International Assets Investment Management LLC now owns 400,040 shares of the health services provider’s stock worth $138,590,000 after purchasing an additional 399,230 shares during the period. 86.99% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
CI has been the topic of a number of analyst reports. Barclays boosted their price objective on The Cigna Group from $405.00 to $420.00 and gave the company an “overweight” rating in a research note on Tuesday, November 5th. JPMorgan Chase & Co. increased their price target on shares of The Cigna Group from $435.00 to $438.00 and gave the stock an “overweight” rating in a report on Wednesday, August 21st. Stephens reaffirmed an “overweight” rating and set a $410.00 price objective on shares of The Cigna Group in a research note on Friday, November 1st. Piper Sandler reiterated an “overweight” rating and issued a $394.00 target price (up from $392.00) on shares of The Cigna Group in a research note on Tuesday, November 5th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $400.00 price target on shares of The Cigna Group in a report on Wednesday, October 23rd. One investment analyst has rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of $394.64.
The Cigna Group Stock Up 1.7 %
CI stock traded up $5.71 during trading on Monday, hitting $334.16. 92,509 shares of the stock traded hands, compared to its average volume of 1,536,146. The stock has a market cap of $92.95 billion, a price-to-earnings ratio of 30.99, a price-to-earnings-growth ratio of 0.99 and a beta of 0.51. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.72 and a quick ratio of 0.72. The Cigna Group has a 1 year low of $253.95 and a 1 year high of $370.83. The firm’s 50 day moving average is $335.43 and its two-hundred day moving average is $338.76.
The Cigna Group (NYSE:CI – Get Free Report) last announced its quarterly earnings results on Thursday, October 31st. The health services provider reported $7.51 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.22 by $0.29. The Cigna Group had a return on equity of 18.42% and a net margin of 1.31%. The firm had revenue of $63.70 billion for the quarter, compared to the consensus estimate of $59.58 billion. During the same period in the prior year, the company posted $6.77 earnings per share. The company’s quarterly revenue was up 29.8% on a year-over-year basis. On average, sell-side analysts anticipate that The Cigna Group will post 28.5 EPS for the current year.
The Cigna Group Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Thursday, December 19th. Shareholders of record on Wednesday, December 4th will be issued a $1.40 dividend. This represents a $5.60 dividend on an annualized basis and a yield of 1.68%. The ex-dividend date is Wednesday, December 4th. The Cigna Group’s dividend payout ratio is 52.83%.
The Cigna Group Company Profile
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
See Also
- Five stocks we like better than The Cigna Group
- What is the FTSE 100 index?
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- What Are Dividend Challengers?
- Discover the 3 Best Performing Stocks That Went Public in 2024
- What are earnings reports?
- 3 Strategic ETFs for Bearish Investors Post-Election
Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.